Therefore, on the basis of the essential role of BCR-ABL P210 in both CML diagnosis and COVID-19, further exploration of the mechanism behind BCR-ABL P210 level alteration and its use as a bridge to monitor disease progression would be beneficial. Here, ABL1 is linked to COVID-19.